Literature DB >> 24829405

The Behavioral Dyscontrol Scale-II with non-elderly veterans.

Robert D Shura1, Jared A Rowland2, Ruth E Yoash-Gantz3.   

Abstract

The Behavioral Dyscontrol Scale-II (BDS-II) is a unique test of frontal lobe function. Although the test was created for use in geriatric populations, it can add useful data to assessments of non-elderly patients. The original scoring system for the BDS was characterized by a low ceiling, limiting its use with higher functioning populations. The BDS-II scoring system was created to address this issue; however, new normative data were not published. This study used a non-elderly Veteran sample to compare the psychometric properties of the BDS and BDS-II scoring systems. The BDS-II showed improved psychometric properties (reductions in skewness and kurtosis) and was significantly more reliable than the BDS. Normative data using both the total sample, as well as the subsample of healthy individuals, are provided for clinical use. Published by Oxford University Press 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  BDS; BDS-II; Executive functioning; Postdeployment; Reliability; Veteran

Mesh:

Year:  2014        PMID: 24829405     DOI: 10.1093/arclin/acu022

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  2 in total

1.  The Post-Deployment Mental Health (PDMH) study and repository: A multi-site study of US Afghanistan and Iraq era veterans.

Authors:  Mira Brancu; H Ryan Wagner; Rajendra A Morey; Jean C Beckham; Patrick S Calhoun; Larry A Tupler; Christine E Marx; Katherine H Taber; Robin A Hurley; Jared Rowland; Scott D McDonald; Jeffrey M Hoerle; Scott D Moore; Harold S Kudler; Richard D Weiner; John A Fairbank
Journal:  Int J Methods Psychiatr Res       Date:  2017-06-27       Impact factor: 4.035

2.  Placebo Response in Fragile X-associated Tremor/Ataxia Syndrome.

Authors:  Emily J Hill; Christopher G Goetz; Glenn T Stebbins; Randi Hagerman; Bichun Ouyang; Deborah A Hall
Journal:  Mov Disord Clin Pract       Date:  2020-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.